Browse by Audience
Skip to content
Papers of the Week
Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia.
Abstract
Studies assessing the comparative effectiveness of methadone versus buprenorphine/naloxone for opioid use disorder in real-world settings are rare – challenged by structural differences in delivery across settings and factors influencing treatment selection. We identified determinants of selection into buprenorphine/naloxone and quantified contributions of individual and provider-level covariates in a setting delivering both medications within the same healthcare settings.